retatrutide study news Big developments in the world of medica weight loss. Eli Lilly jus released results from their Triumph 4 on retatrutide., So what is it? Basically an upgrade of the weight loss drugs we have so Move over #retatrutide the #QuintupleAgonist

In the TRIUMPH-1 Phase 3 trial, participants on the 12 mg dose lost an average of 28.3% of their body weight at 80 weeks, and up to 30.3% at 104 weeks in the study extension

Ruan X, Mueck AO, Beer AM, Naser B, Pickartz S

Pharma-telehealth partnerships are emerging, with Novo Nordisk and Hims & Hers leading the way in delivering FDA-approved GLP-1s through digital platforms

Supporting the body with NAD+ or its building blocks has been linked to better brain metabolism, stronger memory, and healthier neurons

Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages